These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30922834)

  • 1. Cannabinoids, interoception, and anxiety.
    Andrade AK; Renda B; Murray JE
    Pharmacol Biochem Behav; 2019 May; 180():60-73. PubMed ID: 30922834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
    Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB
    Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?
    Fantegrossi WE; Moran JH; Radominska-Pandya A; Prather PL
    Life Sci; 2014 Feb; 97(1):45-54. PubMed ID: 24084047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties.
    Sharpe L; Sinclair J; Kramer A; de Manincor M; Sarris J
    J Transl Med; 2020 Oct; 18(1):374. PubMed ID: 33008420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endocannabinoid system and the brain.
    Mechoulam R; Parker LA
    Annu Rev Psychol; 2013; 64():21-47. PubMed ID: 22804774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies.
    Millán-Guerrero RO; Isais-Millán S
    Gac Med Mex; 2019; 155(5):471-474. PubMed ID: 32091020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terpenoids, Cannabimimetic Ligands, beyond the
    Gonçalves ECD; Baldasso GM; Bicca MA; Paes RS; Capasso R; Dutra RC
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32235333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic nicotine exposure attenuates the effects of Δ
    Manwell LA; Miladinovic T; Raaphorst E; Rana S; Malecki S; Mallet PE
    Brain Behav; 2019 Nov; 9(11):e01375. PubMed ID: 31583843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoids and anxiety.
    Moreira FA; Wotjak CT
    Curr Top Behav Neurosci; 2010; 2():429-50. PubMed ID: 21309120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor mechanisms underlying the CNS effects of cannabinoids: CB
    Hempel B; Xi ZX
    Adv Pharmacol; 2022; 93():275-333. PubMed ID: 35341569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites.
    Tai S; Fantegrossi WE
    Curr Top Behav Neurosci; 2017; 32():249-262. PubMed ID: 28012093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Short-and long-term effects of cannabinoids on memory, cognition and mental illness].
    Sagie S; Eliasi Y; Livneh I; Bart Y; Monovich E
    Harefuah; 2013 Dec; 152(12):737-41, 751. PubMed ID: 24483000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pure Δ
    Romano B; Pagano E; Orlando P; Capasso R; Cascio MG; Pertwee R; Marzo VD; Izzo AA; Borrelli F
    Pharmacol Res; 2016 Nov; 113(Pt A):199-208. PubMed ID: 27498155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling.
    Patel S; Hillard CJ
    J Pharmacol Exp Ther; 2006 Jul; 318(1):304-11. PubMed ID: 16569753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis y los sistemas exocannabinoide y endocannabinoide. Su uso y controversias.
    Millán-Guerrero RO; Isais-Millán S
    Gac Med Mex; 2019; 155(5):508-512. PubMed ID: 31695229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Δ
    Iglesias LP; Bedeschi L; Aguiar DC; Asth L; Moreira FA
    Cannabis Cannabinoid Res; 2023 Feb; 8(1):24-33. PubMed ID: 35984927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of oral delta-9-tetrahydrocannabinol (THC) on autonomic cardiac activity and their relation to subjective and anxiogenic effects.
    Pabon E; Rockwood F; Norman GJ; de Wit H
    Psychophysiology; 2022 Feb; 59(2):e13955. PubMed ID: 34665890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
    Pertwee RG
    Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids & Stress: impact of HU-210 on behavioral tests of anxiety in acutely stressed mice.
    Kinden R; Zhang X
    Behav Brain Res; 2015 May; 284():225-30. PubMed ID: 25707713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence.
    Cooper ZD; Haney M
    Int Rev Psychiatry; 2009 Apr; 21(2):104-12. PubMed ID: 19367504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.